Call for an instant quote 0345 90 80 161
Open Mon to Fri 09:00 - 17:30 | Sat 09:00 - 16:00 (GMT)
10 January 2014 09:27
The first once-daily asthma inhaler has been granted approval for use in Britain
The first ever once-a-day asthma inhaler has been approved for use in Britain.
Relvar Ellipta is the name of the new drug, which uniquely combines a steroid dose to reduce inflammation with a new type of long-acting beta2 agonist to open the airways.
Anyone with asthma travel insurance who is planning to book a dream holiday in 2014 may be hopeful that the new medicine could represent a more convenient and effective way to keep their condition under control.
Some people with asthma will even be able to dispense with their blue inhaler, although others will need to continue to also carry one for when they require immediate relief.
Relvar Ellipta has been approved by the European Commission for prescribing by GPs and asthma specialists to adults and adolescents aged 12 and over, though the NHS drug watchdog NICE is yet to evaluate its cost effectiveness.
The new inhaler can also be used by thousands of people living with the lung disease COPD.
Before granting approval, the European Medicines Agency reviewed results from 10 clinical studies involving 7,783 patients with COPD and 16 trials in 9,326 patients with asthma.
Research has revealed that patients use the grey palm-sized device correctly from the outset and up to six weeks later.
The new treatment offers 24-hour help to asthmatics, many of whom are currently failing to keep the condition under control.
Asthma is an inflammatory disease that constricts the airways and the resulting attacks of breathlessness can be fatal.
More than five million Britons are affected by the condition and many of them experience moderate to severe problems.
Up to three out of four of these patients with moderate to severe problems have "uncontrolled" symptoms despite using one inhaler designed to combat an attack and a second inhaler to keep the airways open.
17 November 2018
London Stansted could soon welcome 43 million passengers a year, after a bid to raise its capacity was approved by the local council.
[more...]
16 November 2018
Switching to a diet low in carbohydrates could see people lose up to 10kg over a three-year period, according to new research.
15 November 2018
Smokers who regularly use vapers are more likely to try and quit smoking for good, new research has suggested.
14 November 2018
Leukaemia patients are now a step closer to personalised treatments after a British study looked at the role gene mutations play in blood cancers.
13 November 2018
A quick scan of the blood vessels in a patient's neck could soon be a critical part of future dementia screening, new research has suggested.
10 November 2018
The NHS spends more than £1 billion a year on prescriptions for people with diabetes, new figures show.
09 November 2018
Woman who smoke, have diabetes, or high blood pressure are more likely to suffer a heart attack than men with the same risk factors, a new study claims.
08 November 2018
Millions of UK pensioners feel they don't have anyone they can turn to for help, a leading charity has warned.
07 November 2018
Over a quarter of medical workers are still reluctant to recommend e-cigarettes to smokers despite being told to do so by health authorities, a new survey has revealed.
06 November 2018
A new direct flight between Manchester and Mumbai could boost the economy of northern England to the tune of £400 million, a new report suggests.
02 November 2018
Air travellers could soon face restrictions on the amount of alcohol they can drink before flying, under plans currently being considered by the government.
01 November 2018
A vegan diet could help people living with diabetes to better manage their condition, a new review suggests.